Clinical Details of Low-Frequency Hearing Loss Observed in Autosomal Dominant MYO7A-Associated Hearing Loss Patients
Genes · 11.03.2026 · 17 (3) · 314
DOI: 10.3390/genes17030314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 11.03.2026. Verfasst von Hiromi Koizumi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Kyouai Hospital, Fujinomiya 418-0067, Japan. Hauptthemen laut MEDLINE: Myosin VIIa. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labor and Welfare of Japan, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background/Objectives: MYO7A is known to be the genetic cause of Usher syndrome type 1, as well as autosomal dominant and autosomal recessive non-syndromic hearing loss. In general, autosomal dominant MYO7A-associated hearing loss shows progressive high-frequency, sloping hearing loss. However, several variants are associated with low-frequency hearing loss. MYO7A-associated low-frequency hearing loss is relatively rare, and the clinical details remain unclear.
Methods
A total of 18,475 Japanese patients with hearing loss were recruited. Targeted massively parallel sequencing of 158 deafness-related genes was performed, and individuals with variants related to MYO7A-associated low-frequency hearing loss were identified.
Results
Among 18,475 hearing loss patients, we identified 60 patients from 44 unrelated families carrying five variants (p.[Asn140Lys; Glu1835Gln], p.Leu479Pro, p.Leu656Val, p.Gly660Arg, and p.Arg668His) for MYO7A-associated low-frequency hearing loss. Patients identified in this study initially showed postlingual-onset mild-to-moderate low-frequency hearing loss; however, high-frequency hearing also deteriorated after the fourth decade, eventually leading to moderate-to-severe flat-type hearing loss. In addition, we performed haplotype analysis for the recurrent variant c.1436T>C:p.Leu479Pro identified in this study and found that this variant is a founder mutation in the Japanese population.
Conclusions
In this study, we were able to clarify the specific features of MYO7A-related low-frequency hearing loss in a significant number of patients. In particular, we clarified the details of hearing deterioration at each frequency. Our findings will be useful for providing more appropriate treatment and follow-up for MYO7A-associated low-frequency hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Kyouai Hospital, Fujinomiya 418-0067, Japan.
- Department of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
ORCID-Profile: Shin-Ya Nishio, Shin-Ichi Usami
Förderung
- Ministry of Health, Labor and Welfare of Japan
- Japan Agency for Medical Research and Development
Zitieren
APA
Koizumi, H., Nishio, S. Y., Usami, S. I., & Deafness Gene Study Consortium (2026). Clinical Details of Low-Frequency Hearing Loss Observed in Autosomal Dominant MYO7A-Associated Hearing Loss Patients. Genes, 17(3), 314. https://doi.org/10.3390/genes17030314
Vancouver
Koizumi H, Nishio SY, Usami SI, Deafness Gene Study Consortium. Clinical Details of Low-Frequency Hearing Loss Observed in Autosomal Dominant MYO7A-Associated Hearing Loss Patients. Genes. 2026;17(3):314. doi:10.3390/genes17030314
BibTeX
@article{Koizumi2026,
author = {Koizumi, Hiromi and Nishio, Shin-Ya and Usami, Shin-Ichi and Deafness Gene Study Consortium, Deafness Gene Study Consortium},
title = {Clinical Details of Low-Frequency Hearing Loss Observed in Autosomal Dominant MYO7A-Associated Hearing Loss Patients},
journal = {Genes},
year = {2026},
volume = {17},
number = {3},
pages = {314},
doi = {10.3390/genes17030314}
}
EUVIMED